help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on May 30, 2006
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2006-0070
A more recent version of this article appeared on August 1, 2006
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
91/8/3011    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gianotti, L.
Right arrow Articles by Borretta, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gianotti, L.
Right arrow Articles by Borretta, G.

Submitted on January 12, 2006
Accepted on May 22, 2006

A slight decrease in renal function further impairs bone mineral density in primary hyperparathyroidism

Laura Gianotti, Francesco Tassone, Flora Cesario, Anna Pia, Paola Razzore, Giampaolo Magro, Alessandro Piovesan, and Giorgio Borretta*

Division of Endocrinology and Metabolism, S. Croce & Carle Hospital, Cuneo, Italy; Division of Endocrinology and Oncology, S.G.Battista Hospital, Turin, Italy

* To whom correspondence should be addressed. E-mail: borretta.g{at}ospedale.cuneo.it.

Background: The impairment of renal function can affect the clinical presentation of primary hyperparathyroidism (PHPT) increasing cardiovascular morbidity, fracture rate and the risk of mortality.

Aim: To study the differences in bone status in a series of consecutive patients affected by PHPT without overt renal failure at diagnosis grouped according to creatinine clearance (Ccr).

Methods: 161 consecutive patients with PHPT were studied. They were divided in two groups based on Ccr. Group A had Ccr ≤ 70 ml/min (n = 49) and group B had Ccr > 70 ml/min (n = 112). PTH, total and ionized serum calcium, urinary calcium and phosphate, serum 25(OH)D3, serum and urinary bone markers, lumbar, forearm and femoral BMD were evaluated.

Results: Patients in group A were older than those in group B (P < 0.0001). PTH levels did not differ in the two groups while both urinary calcium and phosphorous were lower in group A than group B (P < 0.01). Lower BMD was evident in group A at lumbar spine (P < 0.002), forearm (P < 0.0001) and femur (P < 0.01). In asymptomatic PHPT (aPHPT), those with Ccr≤ 70 ml/min had lower forearm BMD than patients with higher Ccr (P < 0.00001). When adjusting for age and BMI, in PHPT BMD at each site persisted being lower (P < 0.05) in group A than group B. In all PHPT subjects, Ccr ({beta} =0.29, P < 0.0005), age ({beta} 0.27, P < 0.00001) and PTH levels ({beta} 0.27, P < 0.0005) were all independently associated with forearm BMD.

Conclusions: In PHPT a slight decrease in renal function is associated with more severe BMD decrease, independently of age, BMI and PTH levels. This association is also present in aPHPT and strengthens the NIH recommendations for surgery in patients with mild PHPT.


Key words: bone • bone mineral density • creatinine clearance • primary hyperparathyroidism







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society